FI962591A - Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä - Google Patents
Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä Download PDFInfo
- Publication number
- FI962591A FI962591A FI962591A FI962591A FI962591A FI 962591 A FI962591 A FI 962591A FI 962591 A FI962591 A FI 962591A FI 962591 A FI962591 A FI 962591A FI 962591 A FI962591 A FI 962591A
- Authority
- FI
- Finland
- Prior art keywords
- growth hormone
- pct
- hormone releasing
- compounds
- date jun
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 3
- 108010051696 Growth Hormone Proteins 0.000 title abstract 3
- 239000000122 growth hormone Substances 0.000 title abstract 3
- 230000003578 releasing effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000007812 deficiency Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 230000017854 proteolysis Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK143893A DK143893D0 (fi) | 1993-12-23 | 1993-12-23 | |
| DK7594 | 1994-01-17 | ||
| DK78194 | 1994-06-30 | ||
| DK116594 | 1994-10-07 | ||
| PCT/DK1994/000486 WO1995017422A1 (en) | 1993-12-23 | 1994-12-22 | Compounds with growth hormone releasing properties |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI962591A0 FI962591A0 (fi) | 1996-06-20 |
| FI962591A true FI962591A (fi) | 1996-06-20 |
Family
ID=27439242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI962591A FI962591A (fi) | 1993-12-23 | 1996-06-20 | Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5854211A (fi) |
| EP (1) | EP0736038B1 (fi) |
| JP (1) | JP3759748B2 (fi) |
| CN (1) | CN1052730C (fi) |
| AT (1) | ATE202785T1 (fi) |
| AU (1) | AU683121B2 (fi) |
| CA (1) | CA2179598A1 (fi) |
| CZ (1) | CZ291382B6 (fi) |
| DE (1) | DE69427650T2 (fi) |
| FI (1) | FI962591A (fi) |
| HU (1) | HU221092B1 (fi) |
| IL (1) | IL112111A (fi) |
| NO (1) | NO315611B1 (fi) |
| PL (1) | PL181286B1 (fi) |
| RU (1) | RU2167881C2 (fi) |
| TW (1) | TW438810B (fi) |
| UA (1) | UA45962C2 (fi) |
| WO (1) | WO1995017422A1 (fi) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09505601A (ja) * | 1993-11-24 | 1997-06-03 | メルク エンド カンパニー インコーポレーテッド | インドリル基含有化合物類および成長ホルモン放出を促進するためのそれらの使用 |
| US6531314B1 (en) | 1996-12-10 | 2003-03-11 | Merck & Co., Inc. | Growth hormone secretagogue receptor family |
| CA2240186A1 (en) | 1995-12-13 | 1997-06-19 | Merck & Co., Inc. | Assays for growth hormone secretagogue receptors |
| GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
| US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
| US6420518B1 (en) | 1997-04-04 | 2002-07-16 | Genetech, Inc. | Insulin-like growth factor agonist molecules |
| WO1998058950A1 (en) | 1997-06-20 | 1998-12-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| PL341707A1 (en) | 1998-01-16 | 2001-04-23 | Novo Nordisk As | Compounds exibiting growth hormone releasing properties |
| US6682908B1 (en) | 1998-07-10 | 2004-01-27 | Merck & Co., Inc. | Mouse growth hormone secretagogue receptor |
| JP2002520011A (ja) | 1998-07-13 | 2002-07-09 | メルク・アンド・カンパニー・インコーポレーテッド | 成長ホルモン分泌促進物質関連受容体および核酸 |
| JP2002522058A (ja) | 1998-08-10 | 2002-07-23 | メルク・アンド・カンパニー・インコーポレーテッド | イヌ成長ホルモン分泌促進物質受容体 |
| DK1141014T3 (da) | 1999-01-06 | 2005-04-11 | Genentech Inc | Insulinlignende vækstfaktor (IGF) i mutantvariant |
| EP1158996A4 (en) | 1999-02-18 | 2005-01-12 | Kaken Pharma Co Ltd | NEW AMID DERIVATIVES AS GROWTH HORMONE SECRETION CONVEYORS |
| WO2000078793A2 (en) * | 1999-06-22 | 2000-12-28 | University Of Louisville Research Foundation, Inc. | Antimicrobial agents |
| AU772752B2 (en) | 1999-07-26 | 2004-05-06 | Baylor College Of Medicine | Super-active porcine growth hormone releasing hormone analog |
| DE60124080T2 (de) * | 2000-03-23 | 2007-03-01 | Elan Pharmaceuticals, Inc., San Francisco | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit |
| AU2001263215A1 (en) | 2000-05-16 | 2001-11-26 | Genentech Inc. | Method for treating cartilage disorders |
| EP1159964B1 (en) | 2000-05-31 | 2009-10-28 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating gastrointestinal motility |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| EP2274978B1 (en) | 2003-09-12 | 2015-05-20 | Tercica, Inc. | Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency |
| WO2005027913A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
| CN101657436A (zh) | 2007-02-09 | 2010-02-24 | 特兰齐姆制药公司 | 大环生长素释放肽受体调节剂及其使用方法 |
| WO2008134828A2 (en) | 2007-05-04 | 2008-11-13 | Katholieke Universiteit Leuven | Tissue degeneration protection |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2015181676A1 (en) | 2014-05-30 | 2015-12-03 | Pfizer Inc. | Carbonitrile derivatives as selective androgen receptor modulators |
| JPWO2016129645A1 (ja) | 2015-02-10 | 2017-10-26 | 富士フイルム株式会社 | 光学部材、光学素子、液晶表示装置および近接眼光学部材 |
| US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4803261A (en) * | 1986-06-27 | 1989-02-07 | The Administrators Of The Tulane Educational Fund | Method for synthesizing a peptide containing a non-peptide |
| US5480869A (en) * | 1990-01-09 | 1996-01-02 | The Regents Of The University Of California | Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues |
| US5486505A (en) * | 1990-07-24 | 1996-01-23 | Polygen Holding Corporation | Polypeptide compounds having growth hormone releasing activity |
| IL98910A0 (en) * | 1990-07-24 | 1992-07-15 | Polygen Holding Corp | Polypeptide compounds having growth hormone releasing activity and pharmaceutical compositions containing them |
| US5663146A (en) * | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| US5470753A (en) * | 1992-09-03 | 1995-11-28 | Selectide Corporation | Peptide sequencing using mass spectrometry |
| SE9300012D0 (sv) * | 1993-01-05 | 1993-01-05 | Astra Ab | New peptides |
| US5559209A (en) * | 1993-02-18 | 1996-09-24 | The General Hospital Corporation | Regulator regions of G proteins |
| HU224345B1 (hu) * | 1993-12-23 | 2005-08-29 | Novo Nordisk A/S. | Növekedési hormont felszabadító tulajdonságú peptidek, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk |
-
1994
- 1994-12-22 IL IL11211194A patent/IL112111A/xx not_active IP Right Cessation
- 1994-12-22 CA CA002179598A patent/CA2179598A1/en not_active Abandoned
- 1994-12-22 RU RU96115195/04A patent/RU2167881C2/ru not_active IP Right Cessation
- 1994-12-22 EP EP95904405A patent/EP0736038B1/en not_active Expired - Lifetime
- 1994-12-22 PL PL94315114A patent/PL181286B1/pl not_active IP Right Cessation
- 1994-12-22 US US08/464,679 patent/US5854211A/en not_active Expired - Fee Related
- 1994-12-22 CZ CZ19961833A patent/CZ291382B6/cs not_active IP Right Cessation
- 1994-12-22 JP JP51711095A patent/JP3759748B2/ja not_active Expired - Fee Related
- 1994-12-22 CN CN94194588A patent/CN1052730C/zh not_active Expired - Fee Related
- 1994-12-22 HU HU9601740A patent/HU221092B1/hu not_active IP Right Cessation
- 1994-12-22 AT AT95904405T patent/ATE202785T1/de active
- 1994-12-22 WO PCT/DK1994/000486 patent/WO1995017422A1/en active IP Right Grant
- 1994-12-22 AU AU13106/95A patent/AU683121B2/en not_active Ceased
- 1994-12-22 UA UA96062484A patent/UA45962C2/uk unknown
- 1994-12-22 DE DE69427650T patent/DE69427650T2/de not_active Expired - Fee Related
-
1995
- 1995-01-13 TW TW084100272A patent/TW438810B/zh active
-
1996
- 1996-06-20 FI FI962591A patent/FI962591A/fi not_active IP Right Cessation
- 1996-06-21 NO NO19962664A patent/NO315611B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1310695A (en) | 1995-07-10 |
| DE69427650T2 (de) | 2001-11-22 |
| JP3759748B2 (ja) | 2006-03-29 |
| RU2167881C2 (ru) | 2001-05-27 |
| EP0736038A1 (en) | 1996-10-09 |
| CA2179598A1 (en) | 1995-06-29 |
| US5854211A (en) | 1998-12-29 |
| CN1052730C (zh) | 2000-05-24 |
| PL315114A1 (en) | 1996-10-14 |
| DE69427650D1 (de) | 2001-08-09 |
| TW438810B (en) | 2001-06-07 |
| NO315611B1 (no) | 2003-09-29 |
| HU9601740D0 (en) | 1996-08-28 |
| HUT74820A (en) | 1997-02-28 |
| WO1995017422A1 (en) | 1995-06-29 |
| IL112111A (en) | 2000-07-16 |
| AU683121B2 (en) | 1997-10-30 |
| FI962591A0 (fi) | 1996-06-20 |
| PL181286B1 (pl) | 2001-07-31 |
| HU221092B1 (en) | 2002-08-28 |
| CZ291382B6 (cs) | 2003-02-12 |
| IL112111A0 (en) | 1995-03-15 |
| JPH09506873A (ja) | 1997-07-08 |
| EP0736038B1 (en) | 2001-07-04 |
| NO962664D0 (no) | 1996-06-21 |
| NO962664L (no) | 1996-08-23 |
| CN1138334A (zh) | 1996-12-18 |
| UA45962C2 (uk) | 2002-05-15 |
| CZ183396A3 (en) | 1997-02-12 |
| ATE202785T1 (de) | 2001-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962591A (fi) | Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä | |
| DE69327536T2 (de) | Fibrinogenrezeptor-antagonisten | |
| ATE185548T1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
| FI964332A (fi) | Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen | |
| DK1077941T3 (da) | Forbindelser med væksthormonfrigörende egenskaber | |
| IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
| TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
| MX9604762A (es) | Nuevas sulfonamidas y procedimiento para su preparacion. | |
| DE60035133D1 (de) | Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten | |
| ATE243521T1 (de) | Verwendung von biopolymeren zur behandlung der muskeln | |
| DK1100824T3 (da) | Forbindelser med væksthormonfrigivende egenskaber | |
| DK0842193T3 (da) | Somatostatin-analoge cykliske peptider med hæmmende aktivitet på væksthormon | |
| EA199700032A1 (ru) | Дезинфицирующий состав "велтолен" | |
| NO20012169D0 (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
| BG106352A (en) | Streptogramin derivatives, production thereof and compositions containing the same | |
| DE69808287D1 (de) | Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid | |
| DE69503635D1 (de) | Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen | |
| TH32887A (th) | สารประกอบทางเคมี |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |